BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
209 hedge funds and large institutions have $1.45B invested in BioTelemetry, Inc. in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 81 reducing their positions, and 34 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
36% more call options, than puts
Call options by funds: $10.6M | Put options by funds: $7.77M
0% more capital invested
Capital invested by funds: $1.45B → $1.45B (+$3.32M)
10% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 81
3% less funds holding
Funds holding: 215 → 209 (-6)
15% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$33.6M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
+$8.55M |
| 3 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$7.43M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.76M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$6.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZCM
Ziegler Capital Management
Chicago,
Illinois
|
-$11.5M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$11.2M |
| 3 |
PM
Pembroke Management
Montreal,
Quebec, Canada
|
-$9.57M |
| 4 |
N
Natixis
Paris,
France
|
-$7.33M |
| 5 |
JP Morgan Chase
New York
|
-$5.84M |
BEAT Hedge Fund Activity: Q3 2020 in Review
209 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2020, worth a combined $1.45B — up 0.23% from $1.45B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of BEAT and 29 opened new positions — a net loss of 5 holders — while 81 trimmed existing stakes and 73 added.
The largest buyer was Millennium Management, adding an estimated $33.6M. The largest seller was Ziegler Capital Management, exiting entirely with an estimated $11.5M sold.
- 209 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2020, down from 215 in Q2 2020.
- Funds reported $1.45B of BioTelemetry, Inc. stock for Q3 2020, up 0.23% quarter-over-quarter.
- 29 funds opened new BioTelemetry, Inc. positions in Q3 2020 and 34 closed out, a net change of -5 holders.
- The largest BioTelemetry, Inc. buyer in Q3 2020 was Millennium Management, an estimated $33.6M added.
- The largest BioTelemetry, Inc. seller in Q3 2020 was Ziegler Capital Management, an estimated $11.5M sold.
Based on aggregated 13F filings for Q3 2020.